Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Graham Susman currently holds 7,061 shares of Immunovant, Inc. (IMVT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Graham Susman has been a net neutral trader of IMVT stock. They have purchased $0 and sold $0 worth of shares.
Robert Graham Susman's most recent insider trade was on Apr 7, 2026, when they sold 7,061 shares at $0.00 per share.
Robert Graham Susman serves as Executive at Immunovant, Inc. (IMVT). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Robert Graham Susman holds the position of Executive at Immunovant, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Robert Graham Susman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert Graham Susman was on Apr 7, 2026, when they purchased $0 worth of IMVT shares. This transaction involved 7,061 shares at N/A per share.
Robert Graham Susman currently owns 7,061 shares of Immunovant, Inc. (IMVT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Graham Susman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Graham Susman has 2 Form 4 filings on record as an insider at Immunovant, Inc..
Set alerts for Robert Graham Susman and 40,000+ other insiders.